GlassScriptPhysician profile
Jordan Johnson
NPI 1669085981
$5,731.69
in general payments reported to CMS, 2019-2025
30 companies · $1,165 in 2025
The $1,165 reported for 2025 was more than what 85% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $599 · 2022: $402 · 2023: $1,396 · 2024: $2,169 · 2025: $1,165.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,223 · Travel and Lodging: $1,507.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,222.86 |
| Travel and Lodging | $1,507.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $3,041.82 | 2021-2025 | Urolift |
| Calyxo, INC. | $361.56 | 2025 | Cvac Aspiration System |
| Sumitomo Pharma America, INC. | $336.48 | 2024-2025 | Gemtesa, Orgovyx |
| Boston Scientific Corporation | $306.49 | 2021-2025 | Rezum Generator, Axonics |
| Tolmar, INC. | $240.23 | 2023-2025 | Eligard, Jatenzo |
| Procept Biorobotics Corporation | $230.45 | 2022-2025 | |
| Abbvie INC. | $200.03 | 2023-2025 | |
| Janssen Pharmaceuticals, INC | $109.47 | 2021 | |
| Urogen Pharma, INC. | $90.08 | 2024-2025 | |
| Laborie Medical Technologies Corp. | $86.56 | 2021-2024 | Optilume Bph Drug Coated Balloon Catheter |
| Bayer Healthcare Pharmaceuticals INC. | $80.62 | 2024 | |
| Convatec INC. | $66.29 | 2025 | |
| Astellas Pharma US INC | $66.19 | 2022-2024 | Myrbetriq |
| Merck Sharp & Dohme LLC | $62.98 | 2024 | Keytruda, Welireg |
| Accord Healthcare, INC. | $59.51 | 2023-2024 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Genetic Laboratories, INC. | $53.80 | 2023 | Prolaris |
| Axonics, INC. | $41.12 | 2023 | Axonics |
| Pfizer INC. | $37.55 | 2024 | |
| Telix Pharmaceuticals | $35.83 | 2025 | Illuccix |
| Vertex Pharmaceuticals Incorporated | $26.94 | 2025 | |
| Ambu INC. | $24.10 | 2025 | |
| Verity Pharmaceuticals INC. | $22.71 | 2024 | Trelstar |
| Baxter Healthcare | $21.66 | 2025 | Tisseel |
| Janssen Biotech, INC. | $21.46 | 2025 | Erleada |
| Olympus America INC. | $20.82 | 2025 | Itind System |
| Angiodynamics, INC. | $20.40 | 2024 | Nanoknife |
| Novartis Pharmaceuticals Corporation | $19.54 | 2024 | |
| Coloplast Corp | $18.28 | 2025 | |
| Alnylam Pharmaceuticals INC. | $16.66 | 2023 | Oxlumo |
| Karl Storz Endoscopy-America | $12.06 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jordan Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.